| Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts HO Vargas, SOV Nunes, MP de Castro, CC Bortolasci, DS Barbosa, ... Journal of affective disorders 150 (3), 923-930, 2013 | 141 | 2013 |
| Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: disease and staging biomarkers and new drug targets CC de Farias, M Maes, KL Bonifácio, CC Bortolasci, A de Souza Nogueira, ... Neuroscience Letters 617, 66-71, 2016 | 137 | 2016 |
| Oxidative stress and inflammatory markers are associated with depression and nicotine dependence HO Vargas, SOV Nunes, MRP de Castro, MM Vargas, DS Barbosa, ... Neuroscience letters 544, 136-140, 2013 | 122 | 2013 |
| The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach G Morris, CC Bortolasci, BK Puri, L Olive, W Marx, A O'Neil, E Athan, ... Life sciences 258, 118166, 2020 | 119 | 2020 |
| Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders G Morris, BK Puri, AJ Walker, M Maes, AF Carvalho, CC Bortolasci, ... Neuroscience & Biobehavioral Reviews 107, 862-882, 2019 | 103 | 2019 |
| The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? G Morris, CC Bortolasci, BK Puri, W Marx, A O'Neil, E Athan, K Walder, ... Cytokine 144, 155593, 2021 | 95 | 2021 |
| Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major … CC Bortolasci, HO Vargas, A Souza-Nogueira, DS Barbosa, EG Moreira, ... Journal of affective disorders 159, 23-30, 2014 | 87 | 2014 |
| Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? S Dodd, AF Carvalho, BK Puri, M Maes, CC Bortolasci, G Morris, M Berk Neuroscience & Biobehavioral Reviews 120, 537-541, 2021 | 62 | 2021 |
| Preventing the development of severe COVID-19 by modifying immunothrombosis G Morris, CC Bortolasci, BK Puri, L Olive, W Marx, A O'Neil, E Athan, ... Life sciences 264, 118617, 2021 | 58 | 2021 |
| Oxidative and nitrosative stress biomarkers in chronic schizophrenia KM Boll, C Noto, KL Bonifácio, CC Bortolasci, A Gadelha, RA Bressan, ... Psychiatry research 253, 43-48, 2017 | 56 | 2017 |
| A review of the neurobiological underpinning of comorbid substance use and mood disorders N Gómez-Coronado, R Sethi, CC Bortolasci, L Arancini, M Berk, S Dodd Journal of Affective Disorders 241, 388-401, 2018 | 55 | 2018 |
| The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders G Morris, BK Puri, CC Bortolasci, A Carvalho, M Berk, K Walder, ... Neuroscience & Biobehavioral Reviews 125, 244-263, 2021 | 43 | 2021 |
| Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity Y Quide, CC Bortolasci, B Spolding, S Kidnapillai, OJ Watkeys, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 105, 110013, 2021 | 40 | 2021 |
| Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder Y Quidé, CC Bortolasci, B Spolding, S Kidnapillai, OJ Watkeys, ... Psychological medicine 49 (16), 2736-2744, 2019 | 40 | 2019 |
| The endocannabinoidome in neuropsychiatry: Opportunities and potential risks G Morris, K Walder, S Kloiber, P Amminger, M Berk, CC Bortolasci, ... Pharmacological Research 170, 105729, 2021 | 38 | 2021 |
| Parkinson's disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways C Coneglian de Farias, M Maes, K Landucci Bonifacio, ... CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 16 …, 2017 | 38 | 2017 |
| Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder CC Bortolasci, HO Vargas, SOV Nunes, LGP de Melo, MRP de Castro, ... Journal of affective disorders 179, 148-155, 2015 | 36 | 2015 |
| Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, ... Acta Neuropsychiatrica 29 (6), 337-346, 2017 | 35 | 2017 |
| The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder S Kidnapillai, CC Bortolasci, M Udawela, B Panizzutti, B Spolding, ... The World Journal of Biological Psychiatry 21 (10), 775-783, 2020 | 34 | 2020 |
| Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis B Panizzutti, D Skvarc, S Lin, S Croce, A Meehan, CC Bortolasci, W Marx, ... International Journal of Molecular Sciences 24 (6), 5250, 2023 | 30 | 2023 |